Related Experiment Videos
Lipases and HDL metabolism
Weijun Jin1, Dawn Marchadier, Daniel J Rader
1University of Pennsylvania School of Medicine, 654 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA.
Insights
High-density lipoprotein (HDL) cholesterol levels are linked to cardiovascular disease. This study explores how secreted lipases impact HDL metabolism and atherosclerosis, offering potential therapeutic targets.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Lipid Metabolism
Background:
- Plasma high-density lipoprotein (HDL) cholesterol levels show a strong inverse association with atherosclerotic cardiovascular disease.
- Overexpression of HDL proteins, like apolipoprotein A-I in animal models, has been shown to reduce atherosclerosis progression and even induce regression.
- HDL metabolism is a recognized therapeutic target for atherosclerotic vascular diseases due to its antiatherogenic properties.
Purpose of the Study:
- To review new developments and insights into the role of secreted lipases in HDL metabolism.
- To examine the relationship between secreted lipases, HDL metabolism, and atherosclerosis.
Main Methods:
- Literature review focusing on recent research regarding secreted lipases and HDL metabolism.
- Analysis of the molecular regulation of HDL metabolism, particularly the influence of extracellular lipases.
- Synthesis of information on the antiatherogenic properties of HDL and their connection to lipase activity.
Main Results:
- HDL possesses multiple antiatherogenic properties, including promoting cholesterol efflux and reverse cholesterol transport.
- HDL exhibits antioxidant, anti-inflammatory, and anticoagulant functions.
- The precise molecular regulation of HDL metabolism is not fully elucidated but is significantly influenced by extracellular lipases.
Conclusions:
- Secreted lipases play a crucial role in regulating HDL metabolism.
- Understanding the role of secreted lipases in HDL metabolism is vital for developing novel therapeutic strategies against atherosclerosis.
- Further research into lipase-HDL interactions could unlock new avenues for treating cardiovascular diseases.
Abstract:
Plasma levels of high-density lipoprotein (HDL) cholesterol are strongly inversely associated with atherosclerotic cardiovascular disease, and overexpression of HDL proteins, such as apolipoprotein A-I in animals, reduces progression and even induces regression of atherosclerosis. Therefore, HDL metabolism is recognized as a potential target for therapeutic intervention of atherosclerotic vascular diseases. The antiatherogenic properties of HDL include promotion of cellular cholesterol efflux and reverse cholesterol transport, as well as antioxidant, anti-inflammatory and anticoagulant properties. The molecular regulation of HDL metabolism is not fully understood, but it is influenced by several extracellular lipases. Here, we focus on new developments and insights into the role of secreted lipases on HDL metabolism and their relationship to atherosclerosis.